ARMO BioSciences

ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors. The Company's robust pipeline includes validated product candidates aimed at treating a variety of cancers in combination with standard of care and emerging immunotherapies.
StateClosed
TypeSubsidiary
Parent CompanyEli Lilly
HQRedwood City, US
Founded2013
Websitearmobio.com
ARMO BioSciences was founded in 2013 and is headquartered in Redwood City, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at ARMO BioSciences

Peter Van Vlasselaer

Peter Van Vlasselaer

Founder, President and Chief Executive Officer
Herb Cross

Herb Cross

CFO
Joseph Leveque

Joseph Leveque

Chief Medical Officer
Martin Oft

Martin Oft

Founder and Vice President of Pre-Clinical and Clinical Development
Russell Kawahata

Russell Kawahata

Vice President of Technical Operations
Show more

ARMO BioSciences Office Locations

ARMO BioSciences has an office in Redwood City
Redwood City, US (HQ)
575 Chesapeake Dr
Show all (1)

ARMO BioSciences Financials and Metrics

Summary Metrics

In total, ARMO BioSciences had raised $167 m. ARMO BioSciences is a subsidiary of Eli Lilly

ARMO BioSciences Revenue

USDFY, 2015FY, 2016FY, 2017

General and administrative expense

2.8m4.6m5.7m

R&D expense

24.7m29.2m37.0m

Operating expense total

27.5m33.8m42.7m
USDFY, 2015FY, 2016FY, 2017

Cash

45.3m26.7m49.5m

Prepaid Expenses

109.0k178.0k2.6m

Current Assets

45.4m27.0m52.1m

PP&E

557.0k429.0k250.0k
USDFY, 2015FY, 2016FY, 2017

Net Income

(27.5m)(33.6m)(42.4m)

Depreciation and Amortization

204.0k207.0k200.0k

Accounts Payable

587.0k4.9m(1.7m)

Cash From Operating Activities

(25.6m)(28.4m)(44.7m)
Show all financial metrics

ARMO BioSciences Online and Social Media Presence

Embed Graph

ARMO BioSciences News and Updates

Lilly Completes Acquisition of ARMO BioSciences

INDIANAPOLIS, June 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO). Lilly's tender offer for all outstanding shares of common stock of ARMO, at a price of $50.00 per share...

Lilly Completes Acquisition of ARMO BioSciences

INDIANAPOLIS, June 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO). Lilly's tender offer for all outstanding shares of common stock of ARMO, at a price of $50.00 per share...

ARMO BioSciences Frequently Asked Questions

  • When was ARMO BioSciences founded?

    ARMO BioSciences was founded in 2013.

  • Who are ARMO BioSciences key executives?

    ARMO BioSciences's key executives are Peter Van Vlasselaer, Herb Cross and Joseph Leveque.

  • Who are ARMO BioSciences competitors?

    Competitors of ARMO BioSciences include Kineta, Allergan and Intra-Cellular Therapies.

  • Where is ARMO BioSciences headquarters?

    ARMO BioSciences headquarters is located at 575 Chesapeake Dr, Redwood City.

  • Where are ARMO BioSciences offices?

    ARMO BioSciences has an office in Redwood City.

  • How many offices does ARMO BioSciences have?

    ARMO BioSciences has 1 office.